V Wealth Advisors LLC Gilead Sciences, Inc. Transaction History

V Wealth Advisors LLC

$123 Million
Q3 2023

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$77.31 - $88.08 $35,794 - $40,781	-463 Reduced 13.06%	3,081 $255,000
Q4 2022 Jan 20, 2023	SELL	$62.32 - $89.47 $16,701 - $23,977	-268 Reduced 7.03%	3,544 $0
Q3 2022 Nov 04, 2022	SELL	$59.54 - $68.01 $33,342 - $38,085	-560 Reduced 12.81%	3,812 $235,000
Q2 2022 Jul 27, 2022	SELL	$57.72 - $65.01 $2,828 - $3,185	-49 Reduced 1.11%	4,372 $270,000
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $57 - $72	1 Added 0.02%	4,421 $263,000
Q4 2021 Feb 17, 2022	SELL	$64.88 - $73.64 $63,647 - $72,240	-981 Reduced 18.16%	4,420 $321,000
Q3 2021 Oct 21, 2021	SELL	$67.69 - $73.03 $54,625 - $58,935	-807 Reduced 13.0%	5,401 $377,000
Q2 2021 Jul 27, 2021	BUY	$63.47 - $69.35 $49,570 - $54,162	781 Added 14.39%	6,208 $424,000
Q1 2021 Apr 20, 2021	SELL	$60.0 - $68.46 $11,760 - $13,418	-196 Reduced 3.49%	5,427 $351,000
Q4 2020 Jan 25, 2021	BUY	$56.65 - $64.55 $318,542 - $362,964	5,623 New	5,623 $328,000
Q3 2020 Oct 13, 2020	SELL	$62.1 - $78.08 $382,349 - $480,738	-6,157 Closed	0 $0
Q2 2020 Jul 29, 2020	SELL	$72.34 - $84.0 $39,931 - $46,368	-552 Reduced 8.23%	6,157 $474,000
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $18,789 - $24,066	300 Added 4.68%	6,709 $502,000
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $7,501 - $8,280	120 Added 1.91%	6,409 $406,000
Q2 2019 Jul 29, 2019	BUY	$61.87 - $69.38 $18,746 - $21,022	303 Added 5.06%	6,289 $425,000
Q1 2019 May 16, 2019	BUY	$62.53 - $70.05 $8,504 - $9,526	136 Added 2.32%	5,986 $378,000
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $98,377 - $128,375	-1,625 Reduced 21.74%	5,850 $399,000
Q3 2018 Oct 31, 2018	SELL	$71.28 - $78.92 $14,968 - $16,573	-210 Reduced 2.73%	7,475 $588,000
Q2 2018 Jul 16, 2018	SELL	$64.88 - $75.68 $18,296 - $21,341	-282 Reduced 3.54%	7,685 $604,000
Q1 2018 Apr 11, 2018	BUY	$72.84 - $88.8 $9,323 - $11,366	128 Added 1.63%	7,967 $578,000
Q4 2017 Jan 19, 2018	BUY	$71.15 - $83.52 $31,590 - $37,082	444 Added 6.0%	7,839 $628,000
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $533,253 - $632,050	7,395	7,395 $594,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of V Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on V Wealth Advisors LLC with notifications on news.

Account